atectura breezhaler
novartis europharm limited - indacaterol acetate, mometasone furoate - astma - lyf til veikindi öndunarvegi sjúkdómum, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
roclanda
santen oy - latanoprost, netarsudil mesilate - glaucoma, open-angle; ocular hypertension - augnlækningar - roclanda is indicated for the reduction of elevated intraocular pressure (iop) in adult patients with primary open-angle glaucoma or ocular hypertension for whom monotherapy with a prostaglandin or netarsudil provides insufficient iop reduction.
efmody
diurnal europe b.v. - hýdrókortisón - adrenal hyperplasia, congenital - barksterar til almennrar notkunar - treatment of congenital adrenal hyperplasia (cah) in adolescents aged 12 years and over and adults.
bropair spiromax
teva b.v. - salmeterol xinafoate, flútikasón nef - astma - lyf til veikindi öndunarvegi sjúkdómum, - bropair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.
seffalair spiromax
teva b.v. - fluticasone propionate, salmeterol xinafoate - astma - lyf til veikindi öndunarvegi sjúkdómum, - seffalair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.
upstaza
ptc therapeutics international limited - eladocagene exuparvovec - aminósýra efnaskipti, innfæddir villur - enzymes, other alimentary tract and metabolism products - upstaza is indicated for the treatment of patients aged 18 months and older with a clinical, molecular, and genetically confirmed diagnosis of aromatic l amino acid decarboxylase (aadc) deficiency with a severe phenotype (see section 5.
roctavian
biomarin international limited - valoctocogene roxaparvovec - antihemorrhagics - treatment of severe haemophilia a (congenital factor viii deficiency) in adult patients without a history of factor viii inhibitors and without detectable antibodies to adeno-associated virus serotype 5 (aav5).
tezspire
astrazeneca ab - tezepelumab - astma - lyf til veikindi öndunarvegi sjúkdómum, - tezspire is indicated as an add-on maintenance treatment in adults and adolescents 12 years and older with severe asthma who are inadequately controlled despite high dose inhaled corticosteroids plus another medicinal product for maintenance treatment.
ultracortenol augnsmyrsli 5 mg/g
agepha pharma s.r.o. - prednisolone pivalate - augnsmyrsli - 5 mg/g
metolazon abcur tafla 5 mg
abcur ab* - metolazonum inn - tafla - 5 mg